Findings

What do systematic reviews say?

207 questions · 244 findings · 20 reviews · Headline outcomes only

No studies found 53 · 21.7%GRADE not reported 6 · 2.5%Very low 50 · 20.5%Low 39 · 16%Moderate 69 · 28.3%High 27 · 11.1%

Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · children with cerebral palsy

1 finding from 1 review

Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · children with cerebral palsy

1 finding from 1 review

Pain (0‐10 cm visual analog scale)‐ Pain at 6‐12 weeks Visual Analog or Verbal Rating Scale. Scale from: 0 to 10. ( · patients with shoulder pain

1 finding from 1 review

Botulinum toxin for shoulder pain 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 76 participants
Low

Number of Adverse Events (AEs) ( · patients with shoulder pain

The intervention showed no clear difference in number of Adverse Events (AEs) ( (low certainty).

1 finding from 1 review

Botulinum toxin for shoulder pain 2010 · Cochrane Headline outcomes only
RR 1.46 [0.64, 3.36]
3 studies · 65 participants
Low

Disability/function ‐ not reported · patients with shoulder pain

The review found no eligible studies for this question.

1 finding from 1 review

Botulinum toxin for shoulder pain 2010 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

WIthdrawals due to Adverse Events ‐ not reported · patients with shoulder pain

The review found no eligible studies for this question.

1 finding from 1 review

Botulinum toxin for shoulder pain 2010 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Serious Adverse Events ‐ not reported · patients with shoulder pain

The review found no eligible studies for this question.

1 finding from 1 review

Botulinum toxin for shoulder pain 2010 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found